![Biosenic Sa](/common/images/company/L_0R55.png)
Medsenic, BioSenic’s subsidiary, signed a new set of licensing and commercialization agreements with Phebra PTY Ltd. PRESS RELEASE – PRIVILEGED INFORMATION The adapted supply and...
BioSenic S.A. : Information on the total number of voting rights and shares PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, June 28, 2024, 7.00 am CET – BIOSENIC...
BioSenic signe une nouvelle convention de souscription pour un maximum de 2,1 millions d'euros en obligations convertibles COMMUNIQUÉ DE PRESSE – INFORMATION PRIVILÉGIÉE...
The Enterprise Court of Nivelles approves the BioSenic restructuring plan PRESS RELEASE – PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, June 14, 2024 7.00am CEST – BioSenic...
BioSenic to host Annual General Meeting on July 12, 2024 PRESS RELEASE – REGULATED INFORMATION Preliminary documents for the Annual General Meeting have been made available on company’s...
BioSenic publie ses résultats annuels 2023 COMMUNIQUÉ DE PRESSE – INFORMATION REGLEMENTEE BioSenic a arrêté le recrutement des patients pour son essai de phase 2b ALLOB à la mi-2023...
BioSenic S.A. : Information on the total number of voting rights and shares PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, May 31, 2024, 7.00 am CEST – BIOSENIC...
BioSenic S.A. : Positive vote of the majority of creditors in favor of the global restructuring plan of BioSenic covering the years 2024-2032, at the Enterprise Court of Nivelles PRESS...
BioSenic présente des données précliniques concluantes sur son médicament ATO pour le contrôle des principaux symptômes au Congrès mondial 2024 sur la sclérose systémique COMMUNIQUE DE PRESSE Des...
BioSenic presents successful preclinical data on its ATO medication for controlling key symptoms at the 2024 Systemic Sclerosis World Congress PRESS RELEASE Preclinical data in a transgenic mouse...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.845 | 3.845 | 3.845 | 12028 | 3.845 | DE |
4 | 0 | 0 | 3.845 | 3.845 | 3.845 | 17900 | 3.845 | DE |
12 | 0 | 0 | 3.845 | 3.845 | 3.845 | 20717 | 3.845 | DE |
26 | 0 | 0 | 3.845 | 3.845 | 3.845 | 15236 | 3.845 | DE |
52 | 0 | 0 | 3.845 | 3.845 | 3.845 | 25391 | 3.845 | DE |
156 | 0 | 0 | 3.845 | 3.845 | 3.845 | 12993 | 3.845 | DE |
260 | 0 | 0 | 3.845 | 3.845 | 3.845 | 12162 | 3.845 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.